
Marcia Stephens Noble
Examiner (ID: 19297, Phone: (571)272-5545 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 1089 |
| Issued Applications | 595 |
| Pending Applications | 110 |
| Abandoned Applications | 393 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11999903
[patent_doc_number] => 20170304058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'Implant for Repairing a Cartilage Defect'
[patent_app_type] => utility
[patent_app_number] => 15/479157
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4948
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15479157
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/479157 | Implant for Repairing a Cartilage Defect | Apr 3, 2017 | Abandoned |
Array
(
[id] => 11915647
[patent_doc_number] => 09783825
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-10
[patent_title] => 'Recombinant adeno-associated vectors for targeted treatment'
[patent_app_type] => utility
[patent_app_number] => 15/479010
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 133
[patent_figures_cnt] => 59
[patent_no_of_words] => 17995
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 375
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15479010
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/479010 | Recombinant adeno-associated vectors for targeted treatment | Apr 3, 2017 | Issued |
Array
(
[id] => 13970763
[patent_doc_number] => 10214724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Methods for differentiation of human pluripotent stem cells to brain microvascular endothelial cells
[patent_app_type] => utility
[patent_app_number] => 15/478463
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 16
[patent_no_of_words] => 17060
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15478463
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/478463 | Methods for differentiation of human pluripotent stem cells to brain microvascular endothelial cells | Apr 3, 2017 | Issued |
Array
(
[id] => 13703231
[patent_doc_number] => 20170362570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => METHODS OF GENERATING GLIAL AND NEURONAL CELLS AND USE OF SAME FOR THE TREATMENT OF MEDICAL CONDITIONS OF THE CNS
[patent_app_type] => utility
[patent_app_number] => 15/468020
[patent_app_country] => US
[patent_app_date] => 2017-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15468020
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/468020 | Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS | Mar 22, 2017 | Issued |
Array
(
[id] => 11908487
[patent_doc_number] => 09777291
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Recombinant adeno-associated vectors for targeted treatment'
[patent_app_type] => utility
[patent_app_number] => 15/465378
[patent_app_country] => US
[patent_app_date] => 2017-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 133
[patent_figures_cnt] => 56
[patent_no_of_words] => 17992
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15465378
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/465378 | Recombinant adeno-associated vectors for targeted treatment | Mar 20, 2017 | Issued |
Array
(
[id] => 12946237
[patent_doc_number] => 09834789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-05
[patent_title] => Recombinant adeno-associated vectors for targeted treatment
[patent_app_type] => utility
[patent_app_number] => 15/465387
[patent_app_country] => US
[patent_app_date] => 2017-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 133
[patent_figures_cnt] => 56
[patent_no_of_words] => 17199
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15465387
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/465387 | Recombinant adeno-associated vectors for targeted treatment | Mar 20, 2017 | Issued |
Array
(
[id] => 12085981
[patent_doc_number] => 09839696
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-12
[patent_title] => 'Recombinant adeno-associated vectors for targeted treatment'
[patent_app_type] => utility
[patent_app_number] => 15/454754
[patent_app_country] => US
[patent_app_date] => 2017-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 133
[patent_figures_cnt] => 59
[patent_no_of_words] => 18005
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15454754
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/454754 | Recombinant adeno-associated vectors for targeted treatment | Mar 8, 2017 | Issued |
Array
(
[id] => 11956093
[patent_doc_number] => 20170260244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'Endoplasmic Reticulum Localization Signals'
[patent_app_type] => utility
[patent_app_number] => 15/450816
[patent_app_country] => US
[patent_app_date] => 2017-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 9202
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15450816
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/450816 | Endoplasmic Reticulum Localization Signals | Mar 5, 2017 | Abandoned |
Array
(
[id] => 14045939
[patent_doc_number] => 20190079076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => INDUCTION OF DIFFERENTIATION OF INDUCED PLURIPOTENT STEM CELLS INTO INTESTINAL EPITHELIAL CELLS
[patent_app_type] => utility
[patent_app_number] => 16/083226
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083226
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/083226 | Induction of differentiation of induced pluripotent stem cells into intestinal epithelial cells | Mar 2, 2017 | Issued |
Array
(
[id] => 11936707
[patent_doc_number] => 20170240857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'DERIVATION OF EMBRYONIC STEM CELLS AND EMBRYO-DERIVED CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/448571
[patent_app_country] => US
[patent_app_date] => 2017-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20471
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15448571
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/448571 | Derivation of embryonic stem cells and embryo-derived cells | Mar 1, 2017 | Issued |
Array
(
[id] => 11963817
[patent_doc_number] => 20170267970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'Three-Dimensional Hydrogels that Support Growth of Physiologically Relevant Tissue and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/444413
[patent_app_country] => US
[patent_app_date] => 2017-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 61738
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15444413
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/444413 | Three-Dimensional Hydrogels that Support Growth of Physiologically Relevant Tissue and Methods of Use Thereof | Feb 27, 2017 | Abandoned |
Array
(
[id] => 17088680
[patent_doc_number] => 11116850
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => AAV-IDUA vector for treatment of MPS I-associated blindness
[patent_app_type] => utility
[patent_app_number] => 16/076654
[patent_app_country] => US
[patent_app_date] => 2017-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 23
[patent_no_of_words] => 14647
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076654
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/076654 | AAV-IDUA vector for treatment of MPS I-associated blindness | Feb 21, 2017 | Issued |
Array
(
[id] => 11943285
[patent_doc_number] => 20170247436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'NON-HUMAN ANIMALS HAVING A MUTANT KYNURENINASE GENE'
[patent_app_type] => utility
[patent_app_number] => 15/435134
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 32346
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15435134
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/435134 | NON-HUMAN ANIMALS HAVING A MUTANT KYNURENINASE GENE | Feb 15, 2017 | Abandoned |
Array
(
[id] => 14342829
[patent_doc_number] => 20190153387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => CULTURE MEDIUM FOR USE IN DIFFERENTIATION OF PLURIPOTENT STEM CELL INTO NEURAL STEM CELL, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/077682
[patent_app_country] => US
[patent_app_date] => 2017-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077682
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077682 | CULTURE MEDIUM FOR USE IN DIFFERENTIATION OF PLURIPOTENT STEM CELL INTO NEURAL STEM CELL, AND USE THEREOF | Feb 13, 2017 | Abandoned |
Array
(
[id] => 14868583
[patent_doc_number] => 20190284533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => VCN ENHANCER COMPOSITIONS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/076946
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43863
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076946
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/076946 | VCN enhancer compositions and methods of using the same | Feb 9, 2017 | Issued |
Array
(
[id] => 17587925
[patent_doc_number] => 11326183
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => VCN enhancer compositions and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 16/076950
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 33092
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076950
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/076950 | VCN enhancer compositions and methods of using the same | Feb 9, 2017 | Issued |
Array
(
[id] => 11662579
[patent_doc_number] => 20170151285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'METHODS AND PRODUCTS FOR TRANSFECTING CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/429798
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 26064
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429798
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/429798 | METHODS AND PRODUCTS FOR TRANSFECTING CELLS | Feb 9, 2017 | Abandoned |
Array
(
[id] => 15024065
[patent_doc_number] => 20190323037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => REPLICATIVE TRANSPOSON SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/077328
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077328
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077328 | Replicative transposon system | Feb 9, 2017 | Issued |
Array
(
[id] => 11663765
[patent_doc_number] => 20170152483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'METHODS AND PRODUCTS FOR TRANSFECTING CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/429795
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 26144
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429795
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/429795 | METHODS AND PRODUCTS FOR TRANSFECTING CELLS | Feb 9, 2017 | Abandoned |
Array
(
[id] => 13899137
[patent_doc_number] => 20190038773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => METHOD TO ENHANCE THE EFFICIENCY OF SYSTEMIC AAV GENE DELIVERY TO THE CENTRAL NERVOUS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/074968
[patent_app_country] => US
[patent_app_date] => 2017-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15461
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -108
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074968
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074968 | Method to enhance the efficiency of systemic AAV gene delivery to the central nervous system | Feb 1, 2017 | Issued |